Abstract:Patients with inflammatory bowel disease (IBD) have an increased risk of 10%-15% developing colorectal cancer (CRC) that is a common disease of high economic costs in developed countries. The CRC has been increasing in recent years and its mortality rates are very high. Multiple biological and biochemical factors are responsible for the onset and progression of this pathology. Moreover, it appears absolutely necessary to investigate the environmental factors favoring the onset of CRC and the promotion of colonic health. The gut microflora, or microbiota, has an extensive diversity both quantitatively and qualitatively. In utero, the intestine of the mammalian fetus is sterile. At birth, the intestinal microbiota is acquired by ingesting maternal anal or vaginal organisms, ultimately developing into a stable community, with marked variations in microbial composition between individuals. The development of IBD is often associated with qualitative and quantitative disorders of the intestinal microbial flora (dysbiosis). The healthy human gut harbours about 10 different bacterial species distributed in colony forming units which colonize the gastrointestinal tract. The intestinal microbiota plays a fundamental role in health and in the progression of diseases such as IBD and CRC. In healthy subjects, the main control of intestinal bacterial colonization occurs through gastric acidity but other factors such as endoluminal temperature, competition between different bacterial strains, peristalsis and drugs can influence the intestinal microenvironment. The microbiota exerts diverse physiological functions to include: growth inhibition of pathogenic microorganisms, synthesis of compounds useful for the trophism of colonic mucosa, regulation of intestinal lymphoid tissue and synthesis of amino acids. Furthermore, mucus seems to play an important role in protecting the intestinal mucosa and maintaining its integrity. Changes in the microbiota composition are mainly influenced by diet and age, as well as genetic factors. Increasing evidence indicates that dysbiosis favors the production of genotoxins and metabolites associated with carcinogenesis and induces dysregulation of the immune response which promotes and sustains inflammation in IBD leading to carcinogenesis. A disequilibrium in gut microflora composition leads to the specific activation of gut associated lymphoid tissue. The associated chronic inflammatory process associated increases the risk of developing CRC. Ulcerative colitis and Crohn's disease are the two major IBDs characterized by an early onset and extraintestinal manifestations, such as rheumatoid arthritis. The pathogenesis of both diseases is complex and not yet fully known. However, it is widely accepted that an inappropriate immune response to microbial flora can play a pivotal role in IBD pathogenesis.

Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis

An Overview of Molecular Profiles in Ulcerative Colitis–Related Cancer

[Ulcerative colitis-associated carcinogenesis : An update]

The molecular landscape of colitis-associated carcinogenesis

Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota

Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer

Inflammation and colorectal cancer: colitis-associated neoplasia

Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation

Immunoprofiles and DNA Methylation of Inflammatory Marker Genes in Ulcerative Colitis-Associated Colorectal Tumorigenesis

Microbiota from patients with ulcerative colitis promote colorectal carcinogenesis in mice

Ulcerative colitis and colon cancer: Biology and surveillance

Exploring the Inflammatory Pathogenesis of Colorectal Cancer

Inflammatory bowel disease and carcinogenesis

Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention

Role of Inflammation in the Development of Colorectal Cancer

Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes

Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation

Colitis-associated neoplasia: molecular basis and clinical translation

Exploring the relationship between ulcerative colitis, colorectal cancer, and prostate cancer

Dynamic changes and functions of macrophages and M1/M2 subpopulations during ulcerative colitis-associated carcinogenesis in an AOM/DSS mouse model

Tumorigenesis in Inflammatory Bowel Disease: Microbiota-Environment Interconnections